Acrobiosystems for English
icon_bulk_orderConsulta masiva/Pedido rápido
user
  1. Cuadro de mandos
  2. Mi perfil
  3. Mi dirección
  4. Mis pedidos
  5. Afiliación a Acro
Iniciar sesión Registro
Promotion
Recombinant Proteins ClearClear history
Recombinant Proteins CloseClose
Browse Products By Molecule Name a-zA-Z
TL1A Hot |GMP IL-2 Hot |FcRn Binding Kit (TR-FRET) New |Claudin 18.2
0
No hay productos en el carro de la compra
Mi carro|Check Out
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Casa > BCHE

BCHE

Brief Information

Name:Butyrylcholinesterase
Target Synonym:BCHED,CHE2,E1,Butyrylcholinesterase,BuChE,EC:3.1.1.8,EC 3.1.1,BCHE,Acylcholine acylhydrolase,Pseudocholinesterase,Cholinesterase,CHE1,Cholinesterase (Serum) 2,Butyrylcholine Esterase,Choline Esterase II,Cholinesterase 1,EC 3.1.1.8
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:3
Lastest Research Phase:Phase 3 Clinical

Product ListCompare or Buy

Product> Filter Results
Por estado del producto :
Por categoría de producto :
Por especies :
Por etiqueta :
Por Conjugado::
Cat. No. Especies Descripción del producto Estructura Pureza Característica
BHE-H52H3 Human Human BCHE / Butyrylcholinesterase Protein, His Tag (active enzyme)
BHE-H52H3-structure
BHE-H52H3-sds
ACRO Quality

Synonym Name

Acylcholine acylhydrolase; BCHE; Butyrylcholine esterase; Butyrylcholinesterase; CHE1; CHE1cholinesterase; Choline esterase II; cholinesterase 1; E1; EC 3.1.1.8; Pseudocholinesterase

Background

BCHE (also known as Butyrylcholinesterase,  pseudocholinesterase, plasma cholinesterase, or BuChE) is a nonspecific cholinesterase enzyme that hydrolyzes many different choline esters. Both acetylcholinesterase and butyrylcholinesterase represent therapeutic targets for ameliorating the cholinergic deficit considered to be responsible for the declines in cognitive, behavioral and global functioning characteristic of Alzheimer's disease (AD).

Clinical and Translational Updates

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Octahydroaminoacridine succinate 华洋-001 Phase 3 Clinical Changchun Huayang High-Tech Co Ltd, Jiangsu Sheneryang High-Tech Co Ltd Alzheimer Disease Details
Benzgalantamine GLN-1062; ALPHA-1062; ALPHA-1062IN Phase 2 Clinical Galantos Pharma GmbH Brain Injuries, Traumatic; Alzheimer Disease Details
Bisnorcymserine ANVS-301 Phase 1 Clinical Horizon Therapeutics PLC Alzheimer Disease Details
Octahydroaminoacridine succinate 华洋-001 Phase 3 Clinical Changchun Huayang High-Tech Co Ltd, Jiangsu Sheneryang High-Tech Co Ltd Alzheimer Disease Details
Benzgalantamine GLN-1062; ALPHA-1062; ALPHA-1062IN Phase 2 Clinical Galantos Pharma GmbH Brain Injuries, Traumatic; Alzheimer Disease Details
Bisnorcymserine ANVS-301 Phase 1 Clinical Horizon Therapeutics PLC Alzheimer Disease Details

This web search service is supported by Google Inc.

totop
Call us
Call us

Germany+49 800 0826645

United Kingdom+44 808 281 3436

Netherlands+31 800 0224992

Switzerland+41 800 040 012

France+33 800 90 78 85

Sweden+46 20 12 76 94

Denmark+45 80 83 07 62

Belgium+32 800 27 125

Email
Correo electrónico
order@acrobiosystems.com
Fax
Fax
+1 888-377-6111
Address
Address
Lichtstrasse 35,4056 Basel, Switzerland
linkedin twitter facebook youtube

Dejar un mensaje

Copyright © 2017 ACROBiosystems. All Rights Reserved
Related Links|Privacy Policy|Terms and Conditions|Legal|Sitemap